15 seconds ago 2010-02-10T04:10:47-08:00
LONDON (Reuters) - British biotech company ReNeuron and a team of doctors in Scotland have won final approval to start a pioneering clinical trial to assess whether stem cell therapy can help patients disabled by stroke. Full Story »
Health Photos

